168 related articles for article (PubMed ID: 17525630)
21. Sensitivity of P504S/alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry for the detection of prostate carcinoma on stored needle biopsies.
Vanguri VK; Woda BA; Jiang Z
Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):365-8. PubMed ID: 16932031
[TBL] [Abstract][Full Text] [Related]
22. AMACR expression in colorectal cancer is associated with left-sided tumor localization.
Marx A; Simon P; Simon R; Mirlacher M; Izbicki JR; Yekebas E; Kaifi JT; Terracciano L; Sauter G
Virchows Arch; 2008 Sep; 453(3):243-8. PubMed ID: 18712414
[TBL] [Abstract][Full Text] [Related]
23. α-Methylacyl-CoA racemase (P504S) is a useful marker for the differential diagnosis of solid pseudopapillary neoplasm of the pancreas.
Shen Y; Wang Z; Zhu J; Chen Y; Gu W; Liu Q
Ann Diagn Pathol; 2014 Jun; 18(3):146-50. PubMed ID: 24675392
[TBL] [Abstract][Full Text] [Related]
24. Alpha-methylacyl-CoA racemase (AMACR/P504S) can distinguish hepatocellular carcinoma and dysplastic hepatocytes from benign nondysplastic hepatocytes.
Guzman G; Wu SJ; Kajdacsy-Balla A; Cotler SJ
Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):411-6. PubMed ID: 17122637
[TBL] [Abstract][Full Text] [Related]
25. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).
Jiang Z; Woda BA; Wu CL; Yang XJ
Am J Clin Pathol; 2004 Aug; 122(2):275-89. PubMed ID: 15323145
[TBL] [Abstract][Full Text] [Related]
26. Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions.
Schostak M; Miller K; Krause H; Schrader M; Kempkensteffen C; Kollermann J
Cancer Detect Prev; 2006; 30(5):449-54. PubMed ID: 17067752
[TBL] [Abstract][Full Text] [Related]
27. Utility of alpha-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer.
Nassar A; Amin MB; Sexton DG; Cohen C
Appl Immunohistochem Mol Morphol; 2005 Sep; 13(3):252-5. PubMed ID: 16082251
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic utility of alpha-methylacyl CoA racemase (P504S) on prostate needle biopsy.
Jiang Z; Woda BA
Adv Anat Pathol; 2004 Nov; 11(6):316-21. PubMed ID: 15505533
[TBL] [Abstract][Full Text] [Related]
29. α-Methylacyl-CoA racemase (AMACR) in gastric cancer: correlation with clinicopathologic data and disease-free survival.
Mroz A; Kiedrowski M; Lewandowski Z
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):313-7. PubMed ID: 23235347
[TBL] [Abstract][Full Text] [Related]
30. alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation.
Kuefer R; Varambally S; Zhou M; Lucas PC; Loeffler M; Wolter H; Mattfeldt T; Hautmann RE; Gschwend JE; Barrette TR; Dunn RL; Chinnaiyan AM; Rubin MA
Am J Pathol; 2002 Sep; 161(3):841-8. PubMed ID: 12213712
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of role of alpha-methyl acyl-coenzyme A racemase/P504S and high molecular weight cytokeratin in diagnosing prostatic lesions.
Jain D; Gupta S; Marwah N; Kalra R; Gupta V; Gill M; Jain N; Lal S; Sen R
J Cancer Res Ther; 2017; 13(1):21-25. PubMed ID: 28508828
[TBL] [Abstract][Full Text] [Related]
32. Value of α-methylacyl-CoA racemase immunochemistry for predicting neoplastic progression in Barrett's oesophagus.
Kastelein F; Biermann K; Steyerberg EW; Verheij J; Kalisvaart M; Looijenga LH; Stoop HA; Walter L; Kuipers EJ; Spaander MC; Bruno MJ;
Histopathology; 2013 Nov; 63(5):630-9. PubMed ID: 24004067
[TBL] [Abstract][Full Text] [Related]
33. Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer.
Gunia S; May M; Scholmann K; Störkel S; Hoschke B; Koch S; Dietel M; Kristiansen G
Virchows Arch; 2008 Aug; 453(2):165-70. PubMed ID: 18648853
[TBL] [Abstract][Full Text] [Related]
34. α-Methylacyl-coenzyme A racemase (AMACR, p504s) is a marker to distinguish malignant melanomas from dysplastic nevi and melanocytic nevi.
Abbas M; Ploch EM; Wehling J; Schipper E; Janciauskiene S; Kreipe HH; Jonigk D
Tumour Biol; 2014 Dec; 35(12):12015-20. PubMed ID: 25149154
[TBL] [Abstract][Full Text] [Related]
35. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM
Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072
[TBL] [Abstract][Full Text] [Related]
36. AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas.
Lakis S; Papamitsou T; Panagiotopoulou C; Kotakidou R; Kotoula V
World J Gastroenterol; 2010 May; 16(20):2476-83. PubMed ID: 20503447
[TBL] [Abstract][Full Text] [Related]
37. Alpha-methylacyl-CoA racemase (AMACR) protein is upregulated in early proliferative lesions of the breast irrespective of apocrine differentiation.
Gatalica Z; Stafford P; Vranic S
Hum Pathol; 2022 Nov; 129():40-46. PubMed ID: 35998819
[TBL] [Abstract][Full Text] [Related]
38. Alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry in Barrett's and colorectal mucosa: only significant overexpression favours a diagnosis of intraepithelial neoplasia.
Sträter J; Wiesmüller C; Perner S; Kuefer R; Möller P
Histopathology; 2008 Feb; 52(3):399-402. PubMed ID: 18081815
[No Abstract] [Full Text] [Related]
39. Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma.
Li W; Cagle PT; Botero RC; Liang JJ; Zhang Z; Tan D
J Exp Clin Cancer Res; 2008 May; 27(1):2. PubMed ID: 18577240
[TBL] [Abstract][Full Text] [Related]
40. Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis.
Witkiewicz AK; Varambally S; Shen R; Mehra R; Sabel MS; Ghosh D; Chinnaiyan AM; Rubin MA; Kleer CG
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1418-23. PubMed ID: 15941950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
